(Q41491959)

1 October 2017

title

Efficacy of inactivated whole HIV-2 vaccines with various adjuvants in cynomolgus monkeys (English)

1 reference

1 October 2017

6

Broliden K

1 reference

1 October 2017

Putkonen P

1

1 reference

1 October 2017

Nilsson C

2

1 reference

1 October 2017

Walther L

3

1 reference

1 October 2017

Ghavamzadeh L

4

1 reference

1 October 2017

Hild K

5

1 reference

1 October 2017

Biberfeld G

7

1 reference

1 October 2017

Thorstensson R

8

1 reference

1 October 2017

publication date

1 February 1994

1 reference

Journal of Medical Primatology

1 October 2017

published in

1 reference

1 October 2017

volume

23

1 reference

1 October 2017

issue

2-3

1 reference

1 October 2017

page(s)

89-94

1 reference

Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.1994.TB00107.X

Vaccine protection against simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.1994.TB00107.X

Observations after human immunodeficiency virus immunization and challenge of human immunodeficiency virus seropositive and seronegative chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.1994.TB00107.X

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.1994.TB00107.X

Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.1994.TB00107.X

Specific and non-specific immunity and protection of macaques against SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.1994.TB00107.X

A formalin-inactivated whole SIV vaccine confers protection in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.1994.TB00107.X

Immune response of chimpanzees after immunization with the inactivated whole immunodeficiency virus (HIV-1), three different adjuvants and challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.1994.TB00107.X

Vaccine protection against HIV-2 infection in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.1994.TB00107.X

Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.1994.TB00107.X

Experimental vaccine protection against feline immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.1994.TB00107.X

Anti-cell antibody in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0684.1994.TB00107.X

10.1111/J.1600-0684.1994.TB00107.X

21 January 2018

Identifiers

DOI

1 reference

1 October 2017

1 reference